"Excelente empresa"

During the past decade, Fundación Oftalmológica de Santander Carlos Ardila Lule conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundación Oftalmológica de Santander Carlos Ardila Lule" are "Atrial Fibrillation" (1 trials), "Cancer" (1 trials), "Prevention of Stroke or Systemic Embolism" (1 trials) and "Solid Tumors Harboring NTRK Fusion" (1 trials). Many other conditions were trialed in "Fundación Oftalmológica de Santander Carlos Ardila Lule" in a lesser frequency.

Most popular intervention types in "Fundación Oftalmológica de Santander Carlos Ardila Lule" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY2757556 (Larotrectinib, Vitrakvi)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundación Oftalmológica de Santander Carlos Ardila Lule" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fundación Oftalmológica de Santander Carlos Ardila Lule". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fundación Oftalmológica de Santander Carlos Ardila Lule, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundación Oftalmológica de Santander Carlos Ardila Lule, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".